294 related articles for article (PubMed ID: 26077142)
21. Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.
Nelson ME; Lahiri S; Chow JD; Byrne FL; Hargett SR; Breen DS; Olzomer EM; Wu LE; Cooney GJ; Turner N; James DE; Slack-Davis JK; Lackner C; Caldwell SH; Hoehn KL
Nat Commun; 2017 Mar; 8():14689. PubMed ID: 28290443
[TBL] [Abstract][Full Text] [Related]
22. A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1.
Hara MR; Kovacs JJ; Whalen EJ; Rajagopal S; Strachan RT; Grant W; Towers AJ; Williams B; Lam CM; Xiao K; Shenoy SK; Gregory SG; Ahn S; Duckett DR; Lefkowitz RJ
Nature; 2011 Aug; 477(7364):349-53. PubMed ID: 21857681
[TBL] [Abstract][Full Text] [Related]
23. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
24. A beta-arrestin 2 signaling complex mediates lithium action on behavior.
Beaulieu JM; Marion S; Rodriguiz RM; Medvedev IO; Sotnikova TD; Ghisi V; Wetsel WC; Lefkowitz RJ; Gainetdinov RR; Caron MG
Cell; 2008 Jan; 132(1):125-36. PubMed ID: 18191226
[TBL] [Abstract][Full Text] [Related]
25. Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.
Delgado E; Okabe H; Preziosi M; Russell JO; Alvarado TF; Oertel M; Nejak-Bowen KN; Zhang Y; Monga SP
J Hepatol; 2015 Feb; 62(2):380-7. PubMed ID: 25457204
[TBL] [Abstract][Full Text] [Related]
26. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.
Nayeb-Hashemi H; Desai A; Demchev V; Bronson RT; Hornick JL; Cohen DE; Ukomadu C
Biochem Biophys Res Commun; 2015 Sep; 465(2):167-73. PubMed ID: 26225745
[TBL] [Abstract][Full Text] [Related]
27. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.
Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ
Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016
[TBL] [Abstract][Full Text] [Related]
28. Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice.
Ip BC; Hu KQ; Liu C; Smith DE; Obin MS; Ausman LM; Wang XD
Cancer Prev Res (Phila); 2013 Dec; 6(12):1304-16. PubMed ID: 24085778
[TBL] [Abstract][Full Text] [Related]
29. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
30. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
Chen N; Nishio N; Ito S; Tanaka Y; Sun Y; Isobe K
Cancer Immunol Immunother; 2015 Jun; 64(6):777-89. PubMed ID: 25832002
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
Jiang J; Zhang Y; Guo Y; Yu C; Chen M; Li Z; Tian S; Sun C
Oncotarget; 2015 Mar; 6(8):6359-72. PubMed ID: 25849943
[TBL] [Abstract][Full Text] [Related]
33. Bergapten inhibits liver carcinogenesis by modulating LXR/PI3K/Akt and IDOL/LDLR pathways.
Pattanayak SP; Bose P; Sunita P; Siddique MUM; Lapenna A
Biomed Pharmacother; 2018 Dec; 108():297-308. PubMed ID: 30227322
[TBL] [Abstract][Full Text] [Related]
34. Reduced expression of arrestin beta 2 by graft monocytes during acute rejection of rat kidneys.
Zakrzewicz A; Krasteva G; Wilhelm J; Dietrich H; Wilker S; Padberg W; Wygrecka M; Grau V
Immunobiology; 2011 Jul; 216(7):854-61. PubMed ID: 21193245
[TBL] [Abstract][Full Text] [Related]
35. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.
Cianfrocca R; Rosanò L; Spinella F; Di Castro V; Natali PG; Bagnato A
Can J Physiol Pharmacol; 2010 Aug; 88(8):796-801. PubMed ID: 20725137
[TBL] [Abstract][Full Text] [Related]
36. Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma.
Peng WT; Sun WY; Li XR; Sun JC; Du JJ; Wei W
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734668
[TBL] [Abstract][Full Text] [Related]
37. β-Arrestin signal complex plays a critical role in adipose differentiation.
Santos-Zas I; Lodeiro M; Gurriarán-Rodríguez U; Bouzo-Lorenzo M; Mosteiro CS; Casanueva FF; Casabiell X; Pazos Y; Camiña JP
Int J Biochem Cell Biol; 2013 Jul; 45(7):1281-92. PubMed ID: 23557604
[TBL] [Abstract][Full Text] [Related]
38. ARRB1 ameliorates liver ischaemia/reperfusion injury via antagonizing TRAF6-mediated Lysine 6-linked polyubiquitination of ASK1 in hepatocytes.
Xu X; Zhang Z; Lu Y; Sun Q; Liu Y; Liu Q; Tian W; Yin Y; Yu H; Sun B
J Cell Mol Med; 2020 Jul; 24(14):7814-7828. PubMed ID: 32445435
[TBL] [Abstract][Full Text] [Related]
39. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
40. Beta-arrestin 2 is required for complement C1q expression in macrophages and constrains factor-independent survival.
Lattin JE; Greenwood KP; Daly NL; Kelly G; Zidar DA; Clark RJ; Thomas WG; Kellie S; Craik DJ; Hume DA; Sweet MJ
Mol Immunol; 2009 Dec; 47(2-3):340-7. PubMed ID: 19783052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
